Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Calderone

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Annals of the Rheumatic Diseases|May 22, 2020
Response to: 'Phsician's global assessment is often useful in SLE, but not always: the case of clinical remission' by Zen <i>et al</i>Anca Askanase, Shereen Oon, Molla Huq, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLECynthia Aranow, Anca Askanase, Shereen Oon, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2013
A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women: the Young at Heart studyMelinda J Carrington, Yih-Kai Chan, Alicia Calderone, et al.
Plos One|March 19, 2013
Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trialJennifer A Whitty, Simon Stewart, Melinda J Carrington, et al.
Arthritis Care & Research|September 20, 2023
Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic SclerosisAlicia Callisto, Dylan Hansen, Jenny Walker, et al.
Seminars in Arthritis and Rheumatism|February 21, 2017
Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity studyVera Golder, Molla Huq, Kate Franklyn, et al.
Arthritis Care & Research|October 18, 2024
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis CohortLaura Taylor, Dylan Hansen, Kathleen Morrisroe, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
BMJ Open|December 10, 2016
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolAlicia Calderone, Wendy Stevens, David Prior, et al.
Advances in Rheumatology (London, England)|May 9, 2024
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort studyRicardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of the Rheumatic Diseases|May 22, 2020
Response to: 'Phsician's global assessment is often useful in SLE, but not always: the case of clinical remission' by Zen <i>et al</i>Anca Askanase, Shereen Oon, Molla Huq, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLECynthia Aranow, Anca Askanase, Shereen Oon, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2013
A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women: the Young at Heart studyMelinda J Carrington, Yih-Kai Chan, Alicia Calderone, et al.
Plos One|March 19, 2013
Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trialJennifer A Whitty, Simon Stewart, Melinda J Carrington, et al.
Arthritis Care & Research|September 20, 2023
Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic SclerosisAlicia Callisto, Dylan Hansen, Jenny Walker, et al.
Seminars in Arthritis and Rheumatism|February 21, 2017
Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity studyVera Golder, Molla Huq, Kate Franklyn, et al.
Arthritis Care & Research|October 18, 2024
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis CohortLaura Taylor, Dylan Hansen, Kathleen Morrisroe, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
BMJ Open|December 10, 2016
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolAlicia Calderone, Wendy Stevens, David Prior, et al.
Advances in Rheumatology (London, England)|May 9, 2024
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort studyRicardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, et al.
Pageof 2